Use este identificador para citar ou linkar para este item:
https://www.arca.fiocruz.br/handle/icict/51625
Tipo de documento
ArtigoDireito Autoral
Acesso aberto
Coleções
- IOC - Artigos de Periódicos [12642]
Metadata
Mostrar registro completo
IMPLEMENTATION OF A COVID-19 GENOMIC SURVEILLANCE REGIONAL NETWORK FOR LATIN AMERICA AND CARIBBEAN REGION
Rede Regional de Vigilância
COVID-19
América Latina e região do Caribe
Genômica
COVID-19
Surveillance Regional Network
Latin America and Caribbean region
Genomic
Autor(es)
Leite, Juliana Almeida
Vicari, Andrea
Perez, Enrique
Siqueira, Marilda Agudo Mendonça Teixeira de
Resende, Paola
Motta, Fernando Couto
Freitas, Lucas
Fernandez, Jorge
Parra, Barbara
Castilho, Andrés
Fasce, Rodrigo
Caballero, Alexander Augusto Martinez
Gresh, Lionel
Aldighier, Sylvain
Gabastou, Jean-Marc
Franco, Leticia
Mendez-Rico, Jairo
Vicari, Andrea
Perez, Enrique
Siqueira, Marilda Agudo Mendonça Teixeira de
Resende, Paola
Motta, Fernando Couto
Freitas, Lucas
Fernandez, Jorge
Parra, Barbara
Castilho, Andrés
Fasce, Rodrigo
Caballero, Alexander Augusto Martinez
Gresh, Lionel
Aldighier, Sylvain
Gabastou, Jean-Marc
Franco, Leticia
Mendez-Rico, Jairo
Afiliação
Health Emergencies Department. Pan American Health Organization. Washington, DC, USA.
Health Emergencies Department. Pan American Health Organization. Washington, DC, USA.
Health Emergencies Department. Pan American Health Organization. Washington, DC, USA.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratorio de Virus Respiratorio e do Sarampo. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratorio de Virus Respiratorio e do Sarampo. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratorio de Virus Respiratorio e do Sarampo. Rio de Janeiro, RJ, Brasil.
Instituto de Salud Pública de Chile. Subdepartamento Genética Molecular. Santiago, Chile.
Instituto de Salud Pública de Chile. Subdepartamento Genética Molecular. Santiago, Chile.
Instituto de Salud Pública de Chile. Subdepartamento Genética Molecular. Santiago, Chile.
Instituto de Salud Pública de Chile. Subdepartamento Enfermidades Virales. Santiago, Chile / Instituto Conmemorativo Gorgas de Estudio de la Salud. Departamento de Investigación en Genómica y Proteómica. Cuidad de Panamá, Panamá.
COVID-19 genomic surveillance regional network implementation in latin america and caribbean region.
Health Emergencies Department. Pan American Health Organization. Washington, DC, USA.
Health Emergencies Department. Pan American Health Organization. Washington, DC, USA.
Health Emergencies Department. Pan American Health Organization. Washington, DC, USA.
Health Emergencies Department. Pan American Health Organization. Washington, DC, USA.
Health Emergencies Department. Pan American Health Organization. Washington, DC, USA.
Health Emergencies Department. Pan American Health Organization. Washington, DC, USA.
Health Emergencies Department. Pan American Health Organization. Washington, DC, USA.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratorio de Virus Respiratorio e do Sarampo. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratorio de Virus Respiratorio e do Sarampo. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratorio de Virus Respiratorio e do Sarampo. Rio de Janeiro, RJ, Brasil.
Instituto de Salud Pública de Chile. Subdepartamento Genética Molecular. Santiago, Chile.
Instituto de Salud Pública de Chile. Subdepartamento Genética Molecular. Santiago, Chile.
Instituto de Salud Pública de Chile. Subdepartamento Genética Molecular. Santiago, Chile.
Instituto de Salud Pública de Chile. Subdepartamento Enfermidades Virales. Santiago, Chile / Instituto Conmemorativo Gorgas de Estudio de la Salud. Departamento de Investigación en Genómica y Proteómica. Cuidad de Panamá, Panamá.
COVID-19 genomic surveillance regional network implementation in latin america and caribbean region.
Health Emergencies Department. Pan American Health Organization. Washington, DC, USA.
Health Emergencies Department. Pan American Health Organization. Washington, DC, USA.
Health Emergencies Department. Pan American Health Organization. Washington, DC, USA.
Health Emergencies Department. Pan American Health Organization. Washington, DC, USA.
Health Emergencies Department. Pan American Health Organization. Washington, DC, USA.
Resumo em Inglês
The timely release of SARS-CoV-2 first genomic sequences allowed the identification of the etiologic agent and development of diagnostic protocols. Genomic sequencing was a crucial step in generating data for driving laboratory response and detections of SARS-CoV-2 since the start of the COVID-19 pandemic. Because of all the progression and achievements that timely release of genetic sequence data represents in the public health response, the Pan American Health Organization (PAHO) in collaboration with countries’ public health laboratories, started implementation of a network for strengthening the Latin America and Caribbean (LAC) region on timely generation of SARS-CoV-2 genomic data. Here we describe the implementation of the COVID-19 Genomic Surveillance Regional Network in the Americas region during the beginning of the pandemic. The establishment of this network has strengthened laboratory response capacity at the country level, as well as facilitated timely release of SARS-CoV-2 genomic information to be used to complement the multiple response strategies for COVID-19 pandemic mitigation. As genomic epidemiology is useful for guiding public health decisions on outbreak and response, we also analysed the first SARS-CoV-2 genomic sequence data from countries of the Latin America and Caribbean Region.
Palavras-chave
ImplementaçãoRede Regional de Vigilância
COVID-19
América Latina e região do Caribe
Genômica
Palavras-chave em inglês
ImplementationCOVID-19
Surveillance Regional Network
Latin America and Caribbean region
Genomic
Compartilhar